

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.91118438 |
| 2 | angiotensin maturation (GO:0002003) | 8.48348360 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.75752302 |
| 4 | drug catabolic process (GO:0042737) | 5.89306691 |
| 5 | phospholipid efflux (GO:0033700) | 5.76324331 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.73370972 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.68861349 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.68861349 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.68861349 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.68861349 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.68861349 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.68861349 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 5.67297420 |
| 14 | regulation of cholesterol esterification (GO:0010872) | 5.63339573 |
| 15 | regulation of bile acid biosynthetic process (GO:0070857) | 5.62471459 |
| 16 | plasma lipoprotein particle assembly (GO:0034377) | 5.51100108 |
| 17 | flavonoid metabolic process (GO:0009812) | 5.47065412 |
| 18 | cholesterol efflux (GO:0033344) | 5.34045103 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.33143218 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.19502469 |
| 21 | protein-lipid complex assembly (GO:0065005) | 5.16803901 |
| 22 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.13953640 |
| 23 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.13953640 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 5.08374662 |
| 25 | negative regulation of sterol transport (GO:0032372) | 5.08374662 |
| 26 | urea cycle (GO:0000050) | 5.05972515 |
| 27 | urea metabolic process (GO:0019627) | 5.05972515 |
| 28 | negative regulation of cell killing (GO:0031342) | 5.05193126 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05193126 |
| 30 | lipoprotein metabolic process (GO:0042157) | 5.03425269 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.90048186 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 4.85989875 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.80829079 |
| 34 | detection of other organism (GO:0098543) | 4.79671644 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.74079813 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 4.73411291 |
| 37 | cholesterol homeostasis (GO:0042632) | 4.73259027 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72324446 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 4.69529103 |
| 40 | sterol homeostasis (GO:0055092) | 4.67487814 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.60181237 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.60181237 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60181237 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 4.57031061 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53632750 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.53452613 |
| 47 | hormone catabolic process (GO:0042447) | 4.50966386 |
| 48 | vitamin A metabolic process (GO:0006776) | 4.48626930 |
| 49 | detection of external biotic stimulus (GO:0098581) | 4.39241576 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.34509537 |
| 51 | detection of bacterium (GO:0016045) | 4.32606995 |
| 52 | sterol transport (GO:0015918) | 4.30929245 |
| 53 | cholesterol transport (GO:0030301) | 4.30929245 |
| 54 | glucose 6-phosphate metabolic process (GO:0051156) | 4.26128779 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 4.18107464 |
| 56 | regulation of cholesterol homeostasis (GO:2000188) | 4.15331968 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.12352711 |
| 58 | digestive system process (GO:0022600) | 4.12165514 |
| 59 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.09969178 |
| 60 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.09969178 |
| 61 | lipoprotein transport (GO:0042953) | 4.07038503 |
| 62 | homocysteine metabolic process (GO:0050667) | 4.06927351 |
| 63 | cellular extravasation (GO:0045123) | 4.03636485 |
| 64 | microglial cell activation (GO:0001774) | 4.00876991 |
| 65 | plasma lipoprotein particle organization (GO:0071827) | 3.99597205 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.96190863 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.96190863 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.95666573 |
| 69 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.95189409 |
| 70 | cysteine metabolic process (GO:0006534) | 3.94714666 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.93365524 |
| 72 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.90358594 |
| 73 | modified amino acid transport (GO:0072337) | 3.89973313 |
| 74 | protein-lipid complex subunit organization (GO:0071825) | 3.89457659 |
| 75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.88750542 |
| 76 | L-phenylalanine catabolic process (GO:0006559) | 3.88750542 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.88522081 |
| 78 | response to host immune response (GO:0052572) | 3.86517903 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86517903 |
| 80 | response to peptidoglycan (GO:0032494) | 3.81016068 |
| 81 | detection of biotic stimulus (GO:0009595) | 3.79767077 |
| 82 | adhesion of symbiont to host cell (GO:0044650) | 3.78803887 |
| 83 | virion attachment to host cell (GO:0019062) | 3.78803887 |
| 84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.78713053 |
| 85 | L-phenylalanine metabolic process (GO:0006558) | 3.78713053 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.77760229 |
| 87 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.77752095 |
| 88 | leukocyte aggregation (GO:0070486) | 3.75768039 |
| 89 | drug transmembrane transport (GO:0006855) | 3.75194319 |
| 90 | regulation of cellular extravasation (GO:0002691) | 3.70866777 |
| 91 | actin filament depolymerization (GO:0030042) | 3.70367380 |
| 92 | nucleobase catabolic process (GO:0046113) | 3.69522780 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.69499789 |
| 94 | cellular glucuronidation (GO:0052695) | 3.68287184 |
| 95 | drug transport (GO:0015893) | 3.67739682 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 3.66882475 |
| 97 | macrophage activation (GO:0042116) | 3.66816137 |
| 98 | drug metabolic process (GO:0017144) | 3.62884767 |
| 99 | neutrophil activation (GO:0042119) | 3.59336864 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59150141 |
| 101 | aromatic amino acid family catabolic process (GO:0009074) | 3.59132624 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.57167843 |
| 103 | response to host (GO:0075136) | 3.57167843 |
| 104 | response to host defenses (GO:0052200) | 3.57167843 |
| 105 | lipid homeostasis (GO:0055088) | 3.55186427 |
| 106 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.54730052 |
| 107 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.51408032 |
| 108 | lysine metabolic process (GO:0006553) | 3.50855289 |
| 109 | lysine catabolic process (GO:0006554) | 3.50855289 |
| 110 | immunoglobulin mediated immune response (GO:0016064) | 3.47497130 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46872925 |
| 112 | negative regulation of digestive system process (GO:0060457) | 3.45736792 |
| 113 | bile acid metabolic process (GO:0008206) | 3.45019256 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 3.44311438 |
| 115 | respiratory burst (GO:0045730) | 3.41461701 |
| 116 | peptide hormone processing (GO:0016486) | 3.40644605 |
| 117 | peptide catabolic process (GO:0043171) | 3.35716635 |
| 118 | epoxygenase P450 pathway (GO:0019373) | 3.35221894 |
| 119 | transepithelial transport (GO:0070633) | 3.34915641 |
| 120 | adhesion of symbiont to host (GO:0044406) | 3.34746038 |
| 121 | tryptophan catabolic process (GO:0006569) | 3.34541290 |
| 122 | indole-containing compound catabolic process (GO:0042436) | 3.34541290 |
| 123 | indolalkylamine catabolic process (GO:0046218) | 3.34541290 |
| 124 | alkaloid metabolic process (GO:0009820) | 3.33573410 |
| 125 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32580375 |
| 126 | kynurenine metabolic process (GO:0070189) | 3.31072499 |
| 127 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30625634 |
| 128 | diacylglycerol metabolic process (GO:0046339) | 3.28381188 |
| 129 | amino-acid betaine metabolic process (GO:0006577) | 3.27892669 |
| 130 | regulation of guanylate cyclase activity (GO:0031282) | 3.27580205 |
| 131 | bile acid biosynthetic process (GO:0006699) | 3.26894483 |
| 132 | glucuronate metabolic process (GO:0019585) | 3.26154729 |
| 133 | uronic acid metabolic process (GO:0006063) | 3.26154729 |
| 134 | glyoxylate metabolic process (GO:0046487) | 3.22997209 |
| 135 | neutrophil mediated immunity (GO:0002446) | 3.22458087 |
| 136 | granulocyte activation (GO:0036230) | 3.21821737 |
| 137 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.20467500 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 3.19066924 |
| 139 | regulation of cholesterol transport (GO:0032374) | 3.18922651 |
| 140 | regulation of sterol transport (GO:0032371) | 3.18922651 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18166856 |
| 142 | dendritic cell migration (GO:0036336) | 3.17958028 |
| 143 | disruption of cells of other organism (GO:0044364) | 3.17482343 |
| 144 | killing of cells of other organism (GO:0031640) | 3.17482343 |
| 145 | tryptophan metabolic process (GO:0006568) | 3.16417431 |
| 146 | fructose metabolic process (GO:0006000) | 3.16413413 |
| 147 | dendritic cell chemotaxis (GO:0002407) | 3.14182112 |
| 148 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12326358 |
| 149 | response to interleukin-15 (GO:0070672) | 3.11576361 |
| 150 | heme transport (GO:0015886) | 3.10895845 |
| 151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09501608 |
| 152 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.08084975 |
| 153 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.06902862 |
| 154 | myeloid cell activation involved in immune response (GO:0002275) | 3.05118170 |
| 155 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.04900082 |
| 156 | leukotriene metabolic process (GO:0006691) | 3.02220698 |
| 157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00073946 |
| 158 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96463912 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.93427567 |
| 160 | T-helper 1 type immune response (GO:0042088) | 2.92610433 |
| 161 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.90225830 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89028883 |
| 163 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87626783 |
| 164 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.83530399 |
| 165 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82851880 |
| 166 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.82030436 |
| 167 | type I interferon signaling pathway (GO:0060337) | 2.80215401 |
| 168 | cellular response to type I interferon (GO:0071357) | 2.80215401 |
| 169 | defense response to fungus (GO:0050832) | 2.80156872 |
| 170 | regulation of cellular amide metabolic process (GO:0034248) | 2.79820200 |
| 171 | B cell receptor signaling pathway (GO:0050853) | 2.79093183 |
| 172 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79013495 |
| 173 | response to type I interferon (GO:0034340) | 2.78491128 |
| 174 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77554109 |
| 175 | cellular response to interleukin-15 (GO:0071350) | 2.77534413 |
| 176 | positive regulation of interferon-alpha production (GO:0032727) | 2.77322842 |
| 177 | neutrophil chemotaxis (GO:0030593) | 2.77163076 |
| 178 | myeloid leukocyte mediated immunity (GO:0002444) | 2.71862118 |
| 179 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71649903 |
| 180 | germinal center formation (GO:0002467) | 2.71109304 |
| 181 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70576401 |
| 182 | neutrophil migration (GO:1990266) | 2.70356358 |
| 183 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.69939827 |
| 184 | regulation of leukocyte degranulation (GO:0043300) | 2.68199249 |
| 185 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67211356 |
| 186 | B cell mediated immunity (GO:0019724) | 2.64512411 |
| 187 | defense response to protozoan (GO:0042832) | 2.64362071 |
| 188 | intestinal cholesterol absorption (GO:0030299) | 10.1311450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.17945575 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.92398562 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.49726200 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.13022603 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.12758996 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.89138656 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.72698245 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99485465 |
| 9 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.59605017 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35183078 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.30766097 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.26433483 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.20623394 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.05442249 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03672330 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02673423 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.99119460 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93278355 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91177510 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.91066595 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77322462 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54363852 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53889672 |
| 24 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.40965970 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24510671 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23629947 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15956712 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12829369 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12265399 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08145877 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.06494587 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04274126 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.02667945 |
| 34 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.01629050 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92915938 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88944383 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86513738 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.81972534 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81843485 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80823907 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78322763 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76875001 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.76282252 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75027266 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74453593 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71878648 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70440765 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.70124983 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68888882 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67077048 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63872139 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61407486 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.60047157 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.56540469 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51268955 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48192867 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47782744 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41300417 |
| 59 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.40598119 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39494755 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35197290 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34400401 |
| 63 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33300168 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31026181 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28189982 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24412593 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23565687 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22235913 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20741100 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20602008 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20286529 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19366827 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19118520 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18073289 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16264918 |
| 76 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15233625 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15059245 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13453970 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13302911 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12641423 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12634754 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11536661 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10373661 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07843233 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07638404 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07504385 |
| 87 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07340956 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07055564 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06279870 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05013806 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04227656 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03329754 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03185631 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03086405 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02429617 |
| 96 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02263742 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01459643 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01377898 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01214821 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00427146 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00243298 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99376410 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99227023 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98926427 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95142030 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94504450 |
| 107 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94375535 |
| 108 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.93181033 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92958883 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91026028 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90867834 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90412558 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.89732664 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89382212 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89109376 |
| 116 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88934120 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88909286 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87873720 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87366311 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87111835 |
| 121 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86658713 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86517675 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86341581 |
| 124 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85639497 |
| 125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85576674 |
| 126 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82774141 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82343400 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80816458 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79781231 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79578255 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78934240 |
| 132 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78543032 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78315937 |
| 134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77730807 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77304790 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76883709 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76649484 |
| 138 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.75674363 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73073359 |
| 140 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.72179054 |
| 141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.70785187 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.70534928 |
| 143 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69595586 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.69383025 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.69142376 |
| 146 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68430200 |
| 147 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.66373074 |
| 148 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65884193 |
| 149 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.65034622 |
| 150 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64592373 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64283903 |
| 152 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.64240839 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64150748 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64103341 |
| 155 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63023357 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.62704223 |
| 157 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.62432213 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62160372 |
| 159 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.61755892 |
| 160 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.59782127 |
| 161 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59592512 |
| 162 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.58812298 |
| 163 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57985577 |
| 164 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57301881 |
| 165 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.57030089 |
| 166 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.56041880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.81743052 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.26009050 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.38594036 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.19382686 |
| 5 | MP0003724_increased_susceptibility_to | 4.76647531 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42318002 |
| 7 | MP0005365_abnormal_bile_salt | 4.24898638 |
| 8 | MP0003252_abnormal_bile_duct | 4.13280225 |
| 9 | MP0009840_abnormal_foam_cell | 3.89272805 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.37457308 |
| 11 | MP0003303_peritoneal_inflammation | 3.30261832 |
| 12 | MP0003436_decreased_susceptibility_to | 3.29754233 |
| 13 | MP0001835_abnormal_antigen_presentation | 3.00922918 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.60575773 |
| 15 | MP0009785_altered_susceptibility_to | 2.58224281 |
| 16 | MP0002419_abnormal_innate_immunity | 2.46543625 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.43052793 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.42330816 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.40405712 |
| 20 | MP0005025_abnormal_response_to | 2.38378403 |
| 21 | MP0008260_abnormal_autophagy | 2.37297489 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.34045986 |
| 23 | MP0001800_abnormal_humoral_immune | 2.17327737 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.08453458 |
| 25 | MP0005671_abnormal_response_to | 2.05639863 |
| 26 | MP0005387_immune_system_phenotype | 2.03823716 |
| 27 | MP0001790_abnormal_immune_system | 2.03823716 |
| 28 | MP0000685_abnormal_immune_system | 2.02887199 |
| 29 | MP0005332_abnormal_amino_acid | 2.02147189 |
| 30 | MP0006082_CNS_inflammation | 2.01691112 |
| 31 | MP0000462_abnormal_digestive_system | 1.99141087 |
| 32 | MP0002723_abnormal_immune_serum | 1.94739500 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.84553168 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.84237159 |
| 35 | MP0001819_abnormal_immune_cell | 1.83589040 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.78345031 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.76496856 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.75600173 |
| 39 | MP0009697_abnormal_copulation | 1.72511519 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.67979484 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.64373056 |
| 42 | MP0000609_abnormal_liver_physiology | 1.63136072 |
| 43 | MP0003866_abnormal_defecation | 1.57608497 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.57237983 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.55518454 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.55032263 |
| 47 | MP0004147_increased_porphyrin_level | 1.54508992 |
| 48 | MP0005409_darkened_coat_color | 1.54028922 |
| 49 | MP0002822_catalepsy | 1.53878727 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.52968580 |
| 51 | MP0004043_abnormal_pH_regulation | 1.48533202 |
| 52 | MP0002132_abnormal_respiratory_system | 1.39523941 |
| 53 | MP0003828_pulmonary_edema | 1.38986626 |
| 54 | MP0000716_abnormal_immune_system | 1.36102865 |
| 55 | MP0002254_reproductive_system_inflammat | 1.35595027 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.34742166 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.32159544 |
| 58 | MP0004883_abnormal_blood_vessel | 1.28815302 |
| 59 | MP0002405_respiratory_system_inflammati | 1.28503928 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.28129906 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.26567774 |
| 62 | MP0001764_abnormal_homeostasis | 1.25324954 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.23861202 |
| 64 | MP0002398_abnormal_bone_marrow | 1.22983511 |
| 65 | MP0005448_abnormal_energy_balance | 1.22816117 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.19174877 |
| 67 | MP0000858_altered_metastatic_potential | 1.14403053 |
| 68 | MP0000538_abnormal_urinary_bladder | 1.12883659 |
| 69 | MP0003868_abnormal_feces_composition | 1.12536504 |
| 70 | MP0005083_abnormal_biliary_tract | 1.11023327 |
| 71 | MP0003075_altered_response_to | 1.10969889 |
| 72 | MP0005381_digestive/alimentary_phenotyp | 1.10870710 |
| 73 | MP0001663_abnormal_digestive_system | 1.10744780 |
| 74 | MP0009278_abnormal_bone_marrow | 1.10712669 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.08188276 |
| 76 | MP0005164_abnormal_response_to | 1.06985872 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.05494896 |
| 78 | MP0002722_abnormal_immune_system | 1.05342825 |
| 79 | MP0002429_abnormal_blood_cell | 1.03957922 |
| 80 | MP0005310_abnormal_salivary_gland | 1.03589034 |
| 81 | MP0001664_abnormal_digestion | 1.00835161 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.00638905 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.00202682 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.99304405 |
| 85 | MP0005451_abnormal_body_composition | 0.98094623 |
| 86 | MP0008004_abnormal_stomach_pH | 0.97610590 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 0.97263435 |
| 88 | MP0009053_abnormal_anal_canal | 0.97023790 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.95901844 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.95359920 |
| 91 | MP0002796_impaired_skin_barrier | 0.92671423 |
| 92 | MP0003448_altered_tumor_morphology | 0.91505168 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.89759776 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.89759776 |
| 95 | MP0001873_stomach_inflammation | 0.88803270 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.88044675 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.86637709 |
| 98 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.86141352 |
| 99 | MP0004381_abnormal_hair_follicle | 0.85492517 |
| 100 | MP0003195_calcinosis | 0.85046901 |
| 101 | MP0004484_altered_response_of | 0.84340651 |
| 102 | MP0005535_abnormal_body_temperature | 0.84333790 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.82451871 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.81634761 |
| 105 | MP0000249_abnormal_blood_vessel | 0.81310231 |
| 106 | MP0003878_abnormal_ear_physiology | 0.79899604 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.79899604 |
| 108 | MP0002006_tumorigenesis | 0.79877506 |
| 109 | MP0000604_amyloidosis | 0.79848477 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.79119398 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.78701006 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.78542415 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.77920325 |
| 114 | MP0000598_abnormal_liver_morphology | 0.73740657 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.73490487 |
| 116 | MP0001851_eye_inflammation | 0.72651065 |
| 117 | MP0003690_abnormal_glial_cell | 0.72304489 |
| 118 | MP0004858_abnormal_nervous_system | 0.71996208 |
| 119 | * MP0009642_abnormal_blood_homeostasis | 0.71848978 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.70092939 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.68368985 |
| 122 | MP0009764_decreased_sensitivity_to | 0.67179337 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.66981823 |
| 124 | MP0004947_skin_inflammation | 0.65312165 |
| 125 | MP0008872_abnormal_physiological_respon | 0.65031614 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.64066298 |
| 127 | MP0006054_spinal_hemorrhage | 0.61984816 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.60338454 |
| 129 | MP0003718_maternal_effect | 0.58718923 |
| 130 | MP0008469_abnormal_protein_level | 0.58462159 |
| 131 | MP0005166_decreased_susceptibility_to | 0.58430949 |
| 132 | MP0000467_abnormal_esophagus_morphology | 0.55157125 |
| 133 | * MP0005376_homeostasis/metabolism_phenot | 0.54654222 |
| 134 | MP0002971_abnormal_brown_adipose | 0.54115516 |
| 135 | MP0003638_abnormal_response/metabolism_ | 0.52659570 |
| 136 | MP0001756_abnormal_urination | 0.52320381 |
| 137 | MP0009763_increased_sensitivity_to | 0.50626640 |
| 138 | MP0000490_abnormal_crypts_of | 0.50220755 |
| 139 | MP0005408_hypopigmentation | 0.50065543 |
| 140 | * MP0002078_abnormal_glucose_homeostasis | 0.49819527 |
| 141 | MP0010678_abnormal_skin_adnexa | 0.48427522 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.48130444 |
| 143 | MP0005334_abnormal_fat_pad | 0.48062926 |
| 144 | MP0003453_abnormal_keratinocyte_physiol | 0.46655867 |
| 145 | MP0008873_increased_physiological_sensi | 0.45894199 |
| 146 | MP0005501_abnormal_skin_physiology | 0.45401328 |
| 147 | MP0009115_abnormal_fat_cell | 0.45102142 |
| 148 | MP0002098_abnormal_vibrissa_morphology | 0.44960466 |
| 149 | MP0000427_abnormal_hair_cycle | 0.44531083 |
| 150 | * MP0005266_abnormal_metabolism | 0.43276910 |
| 151 | MP0001881_abnormal_mammary_gland | 0.39943933 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.39814682 |
| 153 | MP0001849_ear_inflammation | 0.39343232 |
| 154 | MP0000579_abnormal_nail_morphology | 0.38831210 |
| 155 | MP0001216_abnormal_epidermal_layer | 0.34213506 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.33242455 |
| 157 | MP0005023_abnormal_wound_healing | 0.31982863 |
| 158 | MP0001191_abnormal_skin_condition | 0.31920215 |
| 159 | MP0004270_analgesia | 0.30461195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 8.29584797 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.84484449 |
| 3 | Ileus (HP:0002595) | 6.77032075 |
| 4 | Acanthocytosis (HP:0001927) | 6.60391633 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.47254211 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 5.89782562 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 5.61805666 |
| 8 | Xanthomatosis (HP:0000991) | 5.28549538 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.20523765 |
| 10 | Hypolipoproteinemia (HP:0010981) | 5.18902635 |
| 11 | Fat malabsorption (HP:0002630) | 5.08031433 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 5.06774209 |
| 13 | Recurrent abscess formation (HP:0002722) | 5.06688771 |
| 14 | Orchitis (HP:0100796) | 5.04636401 |
| 15 | Myositis (HP:0100614) | 4.95251425 |
| 16 | Malnutrition (HP:0004395) | 4.92546392 |
| 17 | Hydroxyprolinuria (HP:0003080) | 4.60344657 |
| 18 | Abnormality of proline metabolism (HP:0010907) | 4.60344657 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 4.55201921 |
| 20 | Optic neuritis (HP:0100653) | 4.55201921 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35915067 |
| 22 | Abnormality of macrophages (HP:0004311) | 4.35683738 |
| 23 | Hyperglycinuria (HP:0003108) | 4.25274963 |
| 24 | Epidermoid cyst (HP:0200040) | 4.19302768 |
| 25 | Gingivitis (HP:0000230) | 4.17894609 |
| 26 | Poikilocytosis (HP:0004447) | 4.09467445 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 4.06212434 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.05968437 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.95562344 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.94796953 |
| 31 | Deep venous thrombosis (HP:0002625) | 3.77164739 |
| 32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.71633181 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71256099 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.59208215 |
| 35 | Pigmentary retinal degeneration (HP:0001146) | 3.58750574 |
| 36 | Encephalitis (HP:0002383) | 3.57641119 |
| 37 | Stomatitis (HP:0010280) | 3.55616879 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.53440506 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.53440506 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.52079253 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.49043077 |
| 42 | Hyperammonemia (HP:0001987) | 3.48673648 |
| 43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48671104 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 3.46476537 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 3.35732539 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29313143 |
| 47 | Obstructive lung disease (HP:0006536) | 3.29313143 |
| 48 | Meningitis (HP:0001287) | 3.28868519 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 3.24473877 |
| 50 | Recurrent skin infections (HP:0001581) | 3.24154178 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 3.23160705 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 3.22056625 |
| 53 | Keratoconjunctivitis (HP:0001096) | 3.16906465 |
| 54 | Vasculitis (HP:0002633) | 3.15466842 |
| 55 | Abnormality of urine glucose concentration (HP:0011016) | 3.15375730 |
| 56 | Glycosuria (HP:0003076) | 3.15375730 |
| 57 | Peritonitis (HP:0002586) | 3.14097152 |
| 58 | Widely patent fontanelles and sutures (HP:0004492) | 3.10223938 |
| 59 | Spontaneous hematomas (HP:0007420) | 3.10053339 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 3.05590466 |
| 61 | Hyperbilirubinemia (HP:0002904) | 3.02383370 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02045427 |
| 63 | Chronic diarrhea (HP:0002028) | 2.96993148 |
| 64 | Urticaria (HP:0001025) | 2.91707513 |
| 65 | Cupped ribs (HP:0000887) | 2.90356802 |
| 66 | Metabolic acidosis (HP:0001942) | 2.89656765 |
| 67 | Hypoglycemic coma (HP:0001325) | 2.89576054 |
| 68 | Facial shape deformation (HP:0011334) | 2.85588221 |
| 69 | Potter facies (HP:0002009) | 2.85588221 |
| 70 | Hemoptysis (HP:0002105) | 2.85459806 |
| 71 | Chest pain (HP:0100749) | 2.81562773 |
| 72 | Abdominal distention (HP:0003270) | 2.79933168 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.79539529 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.78988863 |
| 75 | Hypoalphalipoproteinemia (HP:0003233) | 2.76254739 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 2.75708471 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72646962 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72646962 |
| 79 | Gingival bleeding (HP:0000225) | 2.66740820 |
| 80 | Cellulitis (HP:0100658) | 2.66382230 |
| 81 | Abnormality of T cell number (HP:0011839) | 2.66251127 |
| 82 | Reticulocytosis (HP:0001923) | 2.63500286 |
| 83 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.62023032 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.62007135 |
| 85 | T lymphocytopenia (HP:0005403) | 2.60924029 |
| 86 | Complement deficiency (HP:0004431) | 2.58741625 |
| 87 | Hyperlipoproteinemia (HP:0010980) | 2.55889956 |
| 88 | Nephrolithiasis (HP:0000787) | 2.53406447 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.52942305 |
| 90 | Ketosis (HP:0001946) | 2.52776230 |
| 91 | Gastrointestinal dysmotility (HP:0002579) | 2.50721253 |
| 92 | Anorexia (HP:0002039) | 2.50025969 |
| 93 | Arterial thrombosis (HP:0004420) | 2.48728961 |
| 94 | Skin nodule (HP:0200036) | 2.47385498 |
| 95 | Abnormal platelet volume (HP:0011876) | 2.46068660 |
| 96 | Abnormality of vitamin metabolism (HP:0100508) | 2.45996922 |
| 97 | Dehydration (HP:0001944) | 2.41536747 |
| 98 | Leukocytosis (HP:0001974) | 2.38924662 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.35826416 |
| 100 | Episodic fever (HP:0001954) | 2.34771321 |
| 101 | Abnormal glucose tolerance (HP:0001952) | 2.34584684 |
| 102 | Prolonged bleeding time (HP:0003010) | 2.33214015 |
| 103 | Pustule (HP:0200039) | 2.32720117 |
| 104 | Osteomyelitis (HP:0002754) | 2.32066449 |
| 105 | Pulmonary embolism (HP:0002204) | 2.29547333 |
| 106 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.29511223 |
| 107 | Abnormality of T cells (HP:0002843) | 2.29498689 |
| 108 | Mesangial abnormality (HP:0001966) | 2.28940272 |
| 109 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.26871312 |
| 110 | Petechiae (HP:0000967) | 2.24115516 |
| 111 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.23348570 |
| 112 | Ketoacidosis (HP:0001993) | 2.22545220 |
| 113 | Gastrointestinal inflammation (HP:0004386) | 2.21469408 |
| 114 | Thin bony cortex (HP:0002753) | 2.20627324 |
| 115 | Confusion (HP:0001289) | 2.19740925 |
| 116 | Polycythemia (HP:0001901) | 2.19597659 |
| 117 | Abnormality of the pleura (HP:0002103) | 2.16723276 |
| 118 | Abnormality of vitamin B metabolism (HP:0004340) | 2.16462131 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 2.15016516 |
| 120 | Hyperglycinemia (HP:0002154) | 2.14436831 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 2.13294138 |
| 122 | Gangrene (HP:0100758) | 2.13263415 |
| 123 | Cholecystitis (HP:0001082) | 2.12820538 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.12820538 |
| 125 | Epistaxis (HP:0000421) | 2.11340260 |
| 126 | Symptomatic seizures (HP:0011145) | 2.10588028 |
| 127 | Abnormality of the intrinsic pathway (HP:0010989) | 2.10425592 |
| 128 | Paresthesia (HP:0003401) | 2.09227710 |
| 129 | Abnormality of T cell physiology (HP:0011840) | 2.08960996 |
| 130 | Steatorrhea (HP:0002570) | 2.07904925 |
| 131 | Skin rash (HP:0000988) | 2.07799319 |
| 132 | Pancreatitis (HP:0001733) | 2.07221310 |
| 133 | Hyperphosphaturia (HP:0003109) | 2.06014499 |
| 134 | Hypochromic anemia (HP:0001931) | 2.04923173 |
| 135 | Recurrent viral infections (HP:0004429) | 2.04620496 |
| 136 | Proximal tubulopathy (HP:0000114) | 2.03916444 |
| 137 | Joint hemorrhage (HP:0005261) | 2.02965674 |
| 138 | Granulocytopenia (HP:0001913) | 2.02601981 |
| 139 | Hypochromic microcytic anemia (HP:0004840) | 2.02437905 |
| 140 | Nausea (HP:0002018) | 2.00832715 |
| 141 | Premature loss of primary teeth (HP:0006323) | 1.99665967 |
| 142 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.98602560 |
| 143 | Increased IgE level (HP:0003212) | 1.98363107 |
| 144 | Late onset (HP:0003584) | 1.94936242 |
| 145 | Hypoglycemic seizures (HP:0002173) | 1.94577655 |
| 146 | Rectal prolapse (HP:0002035) | 1.94097296 |
| 147 | Alveolar cell carcinoma (HP:0006519) | 1.94083220 |
| 148 | Cholelithiasis (HP:0001081) | 1.93922570 |
| 149 | Abnormal gallbladder morphology (HP:0012437) | 1.93625903 |
| 150 | Hypophosphatemia (HP:0002148) | 1.92787825 |
| 151 | Vascular calcification (HP:0004934) | 1.91770831 |
| 152 | Cheilitis (HP:0100825) | 1.90935948 |
| 153 | Sepsis (HP:0100806) | 1.90542483 |
| 154 | Increased IgM level (HP:0003496) | 1.90273496 |
| 155 | Colitis (HP:0002583) | 1.88877546 |
| 156 | Amyloidosis (HP:0011034) | 1.88365055 |
| 157 | Acne (HP:0001061) | 1.87962261 |
| 158 | Abnormality of complement system (HP:0005339) | 1.87605825 |
| 159 | Subacute progressive viral hepatitis (HP:0006572) | 1.87056738 |
| 160 | Recurrent pneumonia (HP:0006532) | 1.86042893 |
| 161 | Hepatocellular carcinoma (HP:0001402) | 1.84821546 |
| 162 | Abnormal biliary tract morphology (HP:0012440) | 1.84193214 |
| 163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83898674 |
| 164 | Glomerulopathy (HP:0100820) | 1.83847998 |
| 165 | Myocardial infarction (HP:0001658) | 1.82982141 |
| 166 | Eosinophilia (HP:0001880) | 1.82882989 |
| 167 | Megaloblastic anemia (HP:0001889) | 1.82848044 |
| 168 | Systemic lupus erythematosus (HP:0002725) | 1.82795808 |
| 169 | Wide cranial sutures (HP:0010537) | 1.82638561 |
| 170 | Abnormality of methionine metabolism (HP:0010901) | 1.82326117 |
| 171 | Abnormal platelet function (HP:0011869) | 1.81610417 |
| 172 | Impaired platelet aggregation (HP:0003540) | 1.81610417 |
| 173 | Abnormality of the endocardium (HP:0004306) | 1.79656608 |
| 174 | Esophageal varix (HP:0002040) | 1.79272416 |
| 175 | Hemorrhage of the eye (HP:0011885) | 1.78581469 |
| 176 | Irritability (HP:0000737) | 1.76550388 |
| 177 | Hypoproteinemia (HP:0003075) | 1.75234098 |
| 178 | Skin ulcer (HP:0200042) | 1.75135186 |
| 179 | Lymphopenia (HP:0001888) | 1.72514301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.19884011 |
| 2 | LMTK2 | 6.04292816 |
| 3 | MST4 | 4.09574419 |
| 4 | MST1R | 4.04459300 |
| 5 | ACVR1B | 3.31117105 |
| 6 | PRKG2 | 3.21641547 |
| 7 | GRK6 | 3.08566688 |
| 8 | IRAK4 | 2.97832019 |
| 9 | AKT3 | 2.92541337 |
| 10 | BLK | 2.83576869 |
| 11 | MAP2K3 | 2.74838155 |
| 12 | ERN1 | 2.66086485 |
| 13 | MAP3K10 | 2.61337700 |
| 14 | RIPK1 | 2.40495789 |
| 15 | PTK6 | 2.15935147 |
| 16 | NME1 | 2.13356814 |
| 17 | TAOK3 | 2.06389017 |
| 18 | NUAK1 | 1.90901388 |
| 19 | PRPF4B | 1.88242334 |
| 20 | ZAP70 | 1.74435126 |
| 21 | MAP3K2 | 1.72984922 |
| 22 | FES | 1.70869828 |
| 23 | EPHA2 | 1.70184864 |
| 24 | JAK3 | 1.67710228 |
| 25 | LATS1 | 1.60843015 |
| 26 | FGR | 1.57787481 |
| 27 | BTK | 1.56866723 |
| 28 | IRAK1 | 1.55968803 |
| 29 | YES1 | 1.48498694 |
| 30 | FGFR4 | 1.45573771 |
| 31 | MET | 1.43809523 |
| 32 | IKBKE | 1.42181050 |
| 33 | SYK | 1.40329841 |
| 34 | MAP2K2 | 1.39957636 |
| 35 | HCK | 1.36413113 |
| 36 | INSRR | 1.35986175 |
| 37 | TXK | 1.35906189 |
| 38 | MAP3K6 | 1.34664549 |
| 39 | EPHA3 | 1.32802739 |
| 40 | BCKDK | 1.26416391 |
| 41 | MAP3K7 | 1.21169435 |
| 42 | EPHB2 | 1.20258890 |
| 43 | LYN | 1.18566387 |
| 44 | TNK2 | 1.17016795 |
| 45 | BMPR2 | 1.13104646 |
| 46 | PRKAA2 | 1.11346167 |
| 47 | MAPK11 | 1.11185857 |
| 48 | IRAK2 | 1.10551705 |
| 49 | EPHB1 | 1.08824289 |
| 50 | ERBB4 | 1.07139650 |
| 51 | STK10 | 1.06482730 |
| 52 | ERBB2 | 1.05496994 |
| 53 | SIK1 | 1.00638996 |
| 54 | TEC | 0.96506458 |
| 55 | MAP3K5 | 0.95071531 |
| 56 | LCK | 0.89264105 |
| 57 | TESK2 | 0.88499338 |
| 58 | CSF1R | 0.86677456 |
| 59 | PTK2 | 0.84377810 |
| 60 | PIK3CA | 0.83969243 |
| 61 | BMX | 0.82921666 |
| 62 | NLK | 0.82634937 |
| 63 | TBK1 | 0.81980168 |
| 64 | TYK2 | 0.80597395 |
| 65 | PKN2 | 0.80495146 |
| 66 | TAOK1 | 0.80373629 |
| 67 | MAP2K6 | 0.75718489 |
| 68 | KIT | 0.72805782 |
| 69 | TGFBR2 | 0.72702817 |
| 70 | TESK1 | 0.72556065 |
| 71 | STK24 | 0.72256911 |
| 72 | PIM1 | 0.71436856 |
| 73 | FYN | 0.69152740 |
| 74 | RET | 0.68995674 |
| 75 | PRKAA1 | 0.68641285 |
| 76 | MATK | 0.67747884 |
| 77 | MAP3K8 | 0.67505064 |
| 78 | MAP3K11 | 0.63045981 |
| 79 | MAP3K13 | 0.62044436 |
| 80 | CDC42BPA | 0.61900087 |
| 81 | MARK2 | 0.60214334 |
| 82 | SCYL2 | 0.59687469 |
| 83 | DDR2 | 0.59472801 |
| 84 | MYLK | 0.59208746 |
| 85 | PBK | 0.58248494 |
| 86 | PDPK1 | 0.57775602 |
| 87 | PTK2B | 0.57220188 |
| 88 | ICK | 0.56704149 |
| 89 | CDK19 | 0.56562166 |
| 90 | MARK3 | 0.55399519 |
| 91 | WNK1 | 0.54857889 |
| 92 | SIK3 | 0.54356859 |
| 93 | TAOK2 | 0.53859976 |
| 94 | TTK | 0.53200946 |
| 95 | PRKCI | 0.52445882 |
| 96 | MAP2K4 | 0.52130025 |
| 97 | KSR1 | 0.51945966 |
| 98 | DAPK2 | 0.51007499 |
| 99 | CSK | 0.50935758 |
| 100 | DYRK1B | 0.49841749 |
| 101 | MAP3K3 | 0.49526884 |
| 102 | FER | 0.48844193 |
| 103 | PRKD2 | 0.48152130 |
| 104 | KSR2 | 0.46670485 |
| 105 | PDK2 | 0.45824576 |
| 106 | IKBKB | 0.45570397 |
| 107 | STK3 | 0.45116641 |
| 108 | GRK1 | 0.44291070 |
| 109 | CDK6 | 0.43681348 |
| 110 | SGK2 | 0.42806858 |
| 111 | PRKACG | 0.42615389 |
| 112 | MAP3K1 | 0.40458782 |
| 113 | RAF1 | 0.39975130 |
| 114 | JAK2 | 0.39924840 |
| 115 | PDK1 | 0.39484245 |
| 116 | MAPKAPK2 | 0.39460408 |
| 117 | OXSR1 | 0.38097193 |
| 118 | IRAK3 | 0.38050109 |
| 119 | STK39 | 0.37626510 |
| 120 | MAP3K12 | 0.36861028 |
| 121 | PIK3CG | 0.36248398 |
| 122 | PAK3 | 0.35579993 |
| 123 | MAP2K1 | 0.35452183 |
| 124 | MAPK4 | 0.34764167 |
| 125 | SGK3 | 0.34650860 |
| 126 | PRKCD | 0.34623850 |
| 127 | RPS6KC1 | 0.34160962 |
| 128 | RPS6KL1 | 0.34160962 |
| 129 | MAPK7 | 0.34112664 |
| 130 | PDK4 | 0.33859797 |
| 131 | PDK3 | 0.33859797 |
| 132 | CAMK1D | 0.33234314 |
| 133 | CDK12 | 0.33198540 |
| 134 | GSK3A | 0.32874048 |
| 135 | RIPK4 | 0.32074672 |
| 136 | PAK4 | 0.31884318 |
| 137 | HIPK2 | 0.31268249 |
| 138 | FGFR3 | 0.30895216 |
| 139 | PRKCQ | 0.30726302 |
| 140 | FGFR2 | 0.30685189 |
| 141 | ITK | 0.30200684 |
| 142 | PRKCZ | 0.30055938 |
| 143 | PRKCA | 0.29817507 |
| 144 | JAK1 | 0.28492646 |
| 145 | FLT3 | 0.28087916 |
| 146 | LRRK2 | 0.24980542 |
| 147 | MAP4K1 | 0.23833870 |
| 148 | MAP3K14 | 0.21401581 |
| 149 | PDGFRA | 0.21254846 |
| 150 | AKT2 | 0.20612895 |
| 151 | SRC | 0.20259518 |
| 152 | TRIB3 | 0.19050725 |
| 153 | ROCK1 | 0.18555989 |
| 154 | STK11 | 0.18509735 |
| 155 | KDR | 0.18216640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.35762604 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.66579950 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.16711941 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13990014 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.11496663 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.02690985 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89702539 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 2.62122506 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58575390 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48726028 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.40105975 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.31617604 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24189881 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20307086 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.15513340 |
| 16 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.12199108 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09666040 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06878860 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.04204344 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.95522279 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85996499 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81597299 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77910594 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74542582 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.69879572 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68572236 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61373893 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.59132182 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57391728 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54450571 |
| 31 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54326259 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52446654 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50311877 |
| 34 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.49917051 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47253153 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47035949 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.45882858 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42515334 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42005724 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.41409195 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41393835 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40016639 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39477451 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37852065 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37382315 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36702350 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34975078 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34637565 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33158742 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.32747448 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31985178 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29586888 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28551232 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28314811 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25264889 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22072338 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19186732 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17006684 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16761682 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16524052 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16192712 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 1.14446563 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14058087 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.13737233 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.13487505 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13436829 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13024453 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12321048 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 1.10937104 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10795829 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10643264 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09363509 |
| 73 | Asthma_Homo sapiens_hsa05310 | 1.06223699 |
| 74 | Measles_Homo sapiens_hsa05162 | 1.04276443 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04098780 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01987020 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01643092 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99265984 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98753546 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97671013 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95739992 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91215553 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90384749 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88311193 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88215008 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87790258 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.85896516 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.85024447 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84661040 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83415381 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82510467 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82096363 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77958196 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.76979658 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75013111 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74693557 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.73319592 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71915025 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.71545386 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.71271970 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70687517 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69435376 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68819946 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62503314 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62476577 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.60493079 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60364376 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60221147 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57597883 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56941530 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56059665 |
| 112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55682611 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55455424 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55426095 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55169535 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.54954767 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54766995 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54346963 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53639894 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50202040 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47943465 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47368639 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46943419 |
| 124 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46682762 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46178134 |
| 126 | Shigellosis_Homo sapiens_hsa05131 | 0.44567839 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44065971 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43383180 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42853810 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41531515 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41104588 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40465224 |
| 133 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.36417765 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27929008 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24315044 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23463146 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.23272083 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22834318 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22785436 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08005254 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07138796 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06741683 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.06131169 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05526084 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.03546549 |
| 146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.02838152 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01262323 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1368002 |
| 149 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0973907 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0970786 |
| 151 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0767154 |
| 152 | Adherens junction_Homo sapiens_hsa04520 | -0.0735698 |
| 153 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0571363 |
| 154 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0509324 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0299733 |
| 156 | Bladder cancer_Homo sapiens_hsa05219 | -0.0291230 |
| 157 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0224788 |
| 158 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0132076 |

